Exercise Intolerance Following COVID-19: What Is the Role of Dysfunctional Breathing?

Carlos Figueiredo; Martin Johnson

doi:10.20344/amp.19526

Exercise Intolerance Following COVID-19: What Is the Role of Dysfunctional Breathing?

Authors

Carlos Figueiredo Pneumology Department. Hospital de Santa Marta. Centro Hospitalar Universitário Lisboa Central. Lisbon. Portugal.
Martin Johnson Scottish Pulmonary Vascular Unit. Queen Elizabeth University Hospital. Glasgow. United Kingdom.

DOI:

https://doi.org/10.20344/amp.19526

Keywords:

COVID-19, Exercise Test, Exercise Tolerance, Post-Acute COVID-19 Syndrome, Respiration

Abstract

N/a.

Downloads

Download data is not yet available.

References

Naeije R, Caravita S. Phenotyping long COVID. Eur Respir J. 2021;58:2101763.

Motiejunaite J, Balagny P, Arnoult F, Mangin L, Bancal C, d’Ortho M, et al. Hyperventilation: a possible explanation for long-lasting exercise intolerance in mild COVID-19 survivors? Front Physiol. 2021;11:614590.

van Voorthuizen EL, van Helvoort HA, Peters JB, van den Heuvel MM, van den Borst B. Persistent exertional dyspnea and perceived exercise intolerance after mild COVID-19: a critical role for breathing dysregulation? Phys Ther. 2022;102:pzac105.

Frésard I, Genecand L, Altarelli M, Gex G, Vremaroiu P, Vremaroiu-Coman A, et al. Dysfunctional breathing diagnosed by cardiopulmonary exercise testing in ‘long COVID’ patients with persistent dyspnoea. BMJ Open Respir Res. 2022;9:e001126.

Freeman R, Wieling W, Axelrod FB, Benditt D, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69-72.

Downloads

Published

2023-04-03

How to Cite

Figueiredo C, Johnson M. Exercise Intolerance Following COVID-19: What Is the Role of Dysfunctional Breathing?. Acta Med Port [Internet]. 2023 Apr. 3 [cited 2024 Dec. 23];36(4):302-3. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/19526

Download Citation

Issue

Vol. 36 No. 4 (2023): April

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.